Your medical cannabis journey simplified: find partnered dispensaries, explore pricing options, earn rewards, and get answers to FAQs, all in one spot.
September 15, 2023 08:00 am ETEstimated Read Time: 3 Minutes
A recent New York vote could make space for the largest adult-use cannabis market on the East Coast. New York regulators voted Tuesday to allow the state’s medical cannabis operators to apply for adult-use retail licenses.
Essentially, this vote means that the multistate operators who acquired the majority of the state’s “registered organization” permits may now enter what could be the largest cannabis industry market on the East Coast.
What Does This Vote Mean for the New York Cannabis Market?
Regulators will begin to accept applications from qualified organizations seeking a retail or microbusiness license starting Oct. 4. These applications will close Dec. 23.
The vote, confirming a proposal from May by the New York Office of Cannabis Management (OCM), carries significant implications.
Litigation aimed at expanding licensing opportunities for all applicants may become irrelevant. This lawsuit was initiated by some of the same MSOs who previously sued the state in March, operating under the banner of the Coalition for Access to Safe and Regulated Cannabis.
Secondly, the state’s social equity applicants and existing license holders are feeling abandoned and let down. Many among them are still awaiting the opportunity to open their establishments due to bureaucratic delays and ongoing legal challenges, which have hindered the state’s ambitious Conditional Adult-Use Retail Dispensary (CAURD) program.
This vote occurred one week after the CEOs of four multistate operators passionately appealed to New York Governor Kathy Hochul for expedited entry into the state’s adult-use market.
Apply For Your Medical Marijuana Card Today
Veriheal has satisfied hundreds of thousands of patients nationwide
Get approved or your money back
Appointments available on-demand
Customer support available 24/7
Nevertheless, Barry Carmody, a spokesperson for the New York Medical Cannabis Industry Association (NYMCIA), explored the historic nature of this vote at a Cannabis Control Board meeting in Albany: “Today marks a pivotal step toward expanding and sustaining the state’s medical program and creation of an economically viable and equitable adult-use cannabis industry in New York.”
Ongoing Litigation Shadows New York’s Adult-Use Licensing Process
While this vote will impact multistate cannabis operations, several lawsuits are still at play that will affect the final legislation.
OCM is facing two separate pending lawsuits, one from the state’s Management Services Organizations and another by a group of veterans previously shut out by the CAURD program.
These “service-disabled” veterans filed a suit against cannabis regulators earlier this year that challenged the constitutional legality of the CAURD program. This lawsuit argued that CAURD’s system of issuing licenses to certain social equity applicants violated state law while excluding veterans from these application benefits.
Will This Vote Affect New York Cannabis Small Business?
Cannabis farmers and small business owners in New York spoke back to the OCM about how this legislation will impact their operations. Essentially, many small cannabis business owners feel as though the vote favors “big cannabis,” squashing the efforts of state-based organizations.
The Cannabis Association of New York (CANY) represents these smaller and state-based cannabis businesses. As such, CANY is pushing for three changes to the existing legislation:
Move to eradicate the state’s illicit market
Implement identical canopy limits on small businesses and registered organizations
Reform the state’s potency tax that charges higher tax rates for cannabis concentrates.
Kymberly is a Pennsylvania native and cannabis enthusiast. When she's not scouring the racks at the thrift store, Kym can be found rollerblading with her dog or just goofin' around.
Blunts: What are they exactly, and how do they affect your body? If you’re interested in smoking blunts—or already smoke them—this guide is for you. We’ll cover everything you need to know about this popular cannabis intake method, including how they’re made, how they differ from spliffs and joints, risks of use, and alternative intake…
People have been smoking joints for a long time. The first rolling papers surfaced around the early 1500s in Alcoy, Spain. These weren’t like the rolling papers we know today though. To start, these papers were intended for tobacco, not cannabis. They were made of hemp along with other textiles and lacked an adhesive gum…
“Stoned,” “high,” “tripping,” and “baked,” are all terms engrained in the cannabis community. These metaphorical descriptions contribute to how we perceive, interpret, and learn from the experiences produced by cannabis consumption. Cannabis experiences, of course, are unique and highly variable. Specific plant strains, the presence of other cannabinoids, different delivery methods, and a user’s individual…
Cannabis seeds, aka beans, come in a lot of different varieties. On top of countless different strains to choose from, there are regular cannabis seeds, feminized cannabis seeds, auto-flowering cannabis seeds, and ruderalis cannabis seeds. Ruderalis cannabis seeds are the least common out of the group, generally only used by breeders. Regular cannabis seeds produce…
With fall well underway, many growers are getting ready to harvest their cannabis cards. When it comes to harvests, you better have a plan ready, or things will get really hectic real quick. Thankfully, this doesn’t have to be. With a little due diligence and some planning, you can make harvesting your outdoor cannabis plants…
We use our own as well as third party cookies to improve your site experience and the services we make available. You can learn more about our use of cookies in our Privacy Policy.
Content Disclamer
The statements made regarding cannabis products on this website have not been evaluated by the Food and Drug Administration (FDA). Cannabis is not an FDA-approved substance and is still illegal under federal law. The information provided on this website is intended for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It is not intended as medical advice and should not be considered as a substitute for advice from a healthcare professional. We strongly recommend that you consult with a physician or other qualified healthcare provider before using any cannabis products. The use of any information provided on this website is solely at your own risk.